Prevalence of erm genes encoding macrolide-lincosamide-streptogramin (MLS) resistance among clinical isolates of Staphylococcus aureus in a Turkish university hospital

Clinical Microbiology and Infection

Volumn 12, Issue 8, 2006, Pages 797-799

  Saribas, Z ^a   Tunckanat, F ^a   Pinar, A ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Erm genes; Lincosamide; Macrolide; MLS resistance; Staphylococcus aureus; Streptogramin B

Indexed keywords

AZITHROMYCIN; BACTERIAL DNA; BACTERIAL PROTEIN; BACTERIAL RNA; CLARITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; JOSAMYCIN; LINCOSAMIDE; MACROLIDE; METHYLTRANSFERASE; METICILLIN; MIDECAMYCIN; MIKAMYCIN B; RNA 23S; ROXITHROMYCIN; SPIRAMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; DNA DETERMINATION; GENE EXPRESSION; GENE INSERTION; GENE LOCATION; GENETIC CODE; GENETIC IDENTIFICATION; HUMAN; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; TURKEY (REPUBLIC); UNIVERSITY HOSPITAL;

STAPHYLOCOCCUS AUREUS;

EID: 33745606953     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2006.01486.x     Document Type: Article

References (20)

1. Roberts MC, Sutcliffe J, Courvalin P, Jensen BL, Rood J, Seppala H. Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants. Antimicrob Agents Chemother 1999; 43: 2823-2830.
2. Jones ME, Karlowsky JA, Draghi DC, Thornsberry C, Sahm DF, Nathwani D. Epidemiology and antibiotic susceptibility of bacteria causing skin and soft tissue infections in the USA and Europe: A guide to appropriate antimicrobial therapy. Int J Antimicrob Agents 2003; 22: 406-419.
3. Darley ESR, MacGowan AP. Antibiotic treatment of Gram-positive bone and joint infections. J Antimicrob Chemother 2004; 53: 928-935.
4. Prunier AL, Malbruny B, Tande D, Picard B, Leclercq R. Clinical isolates of Staphylococcus aureus with ribosomal mutations conferring resistance to macrolides. Antimicrob Agents Chemother 2002; 46: 3054-3056.
5. Wondrack L, Massa M, Yang BV, Sutcliffe J. Clinical strain of Staphylococcus aureus inactivates and causes efflux of macrolides. Antimicrob Agents Chemother 1996; 40: 992-998.
6. Leclercq R, Courvalin P. Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification. Antimicrob Agents Chemother 1991; 35: 1267-1272.
7. Steward CD, Raney PM, Morrell AK et al. Testing for induction of clindamycin resistance in erythromycin-resistant isolates of Staphylococcus aureus. J Clin Microbiol 2005; 43: 1716-1721.
8. Schmitz FJ, Petridou J, Astfalk N et al. Structural alterations in the translational attenuator of constitutively expressed erm (A) genes in Staphylococcus aureus. Antimicrob Agents Chemother 2001; 45: 1603-1604.
9. Ito T, Katayama Y, Asada K et al. Structural comparison of three types of staphylococcal casette chromosome mec integrated in the chromosome in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2001; 45: 1323-1336.
10. Chung WO, Werckenthin C, Schwarz S, Roberts MC. Host range of the ermF rRNA methylase gene in bacteria of human and animal origin. J Antimicrob Chemother 1999; 43: 5-14.
11. Matsuoka M, Inoue M, Nakajima Y, Endo Y. New erm gene in Staphylococcus aureus clinical isolates. Antimicrob Agents Chemother 2002; 46: 211-215.
12. Melter O, Sousa MA, Urbaskova P, Jakubu V, Zemlickova H, Lencastre H. Update on the major clonal types of methicillin-resistant Staphylococcus aureus in the Czech Republic. J Clin Microbiol 2003; 41: 4998-5005.
13. Lina G, Quaglia A, Reverdy ME, Leclercq R, Vandenesch F, Etienne J. Distribution of genes encoding resistance to macrolides, lincosamides, and streptogramins among staphylococci. Antimicrob Agents Chemother 1999; 43: 1062-1066.
14. Kim HB, Lee B, Jang HC et al. A high frequency of macrolide-lincosamide-streptogramin resistance determinants in Staphylococcus aureus isolated in South Korea. Microb Drug Resist 2004; 10: 248-254.
15. Spiliopoulou I, Petinaki E, Papandreou P, Dimitracopoulos G. e rm (C) is the predominant genetic determinant for the expression of resistance to macrolides among methicillin-resistant Staphylococcus aureus clinical isolates in Greece. J Antimicrob Chemother 2004; 53: 814-817.
16. Tunckanat F, Arikan S. Phenotypes of staphylococcal resistance to macrolides-lincosamides-streptogramin B (MLS) in a Turkish University hospital. Zentralbl Bakteriol 2000; 289: 827-833.
17. Jenssen WD, Thakker-Varia S, Dubin DT, Weinstein MP. Prevalence of macrolides-lincosamides-streptogramin B resistance and erm gene classes among clinical strains of staphylococci and streptococci. Antimicrob Agents Chemother 1987; 31: 883-888.
18. National Committee for Clinical Laboratory Standards. Performance standards for dilution antimicrobial susceptibility tests, 6th edn. Approved standard M7-A6. Wayne, PA: NCCLS, 2003.
19. Sambrook J, Russell DW. Molecular cloning: A laboratory manual, 3rd edn. New York: Cold Spring Harbor Laboratory Press, 2001.
20. Eady EA, Ross JI, Tipper JL, Walters CE, Cove JH, Noble WC. Distribution of genes encoding erythromycin ribosomal methylases and erythromycin efflux pump in epidemiologically distinct groups of staphylococci. J Antimicrob Chemother 1993; 31: 211-217.